Turku PET Centre

Medicine and Dentistry

1. Fluorine-18 100%
2. Multiple Sclerosis 88%
3. Positron Emission Tomography 76%
4. Fitness 69%
5. Folate Receptor 67%
6. Lesion 66%
7. Insulin Sensitivity 62%
8. Glucose Uptake 61%
9. Folic Acid 59%
10. Thalamus 58%
11. Liver 58%
12. Carbon 11 56%
13. Association 54%
14. Radioactive Tracer 53%
15. Fatty Acid Transport 48%
16. Apoplexy 48%
17. Radiation Therapy 48%
18. Exercise 48%
19. Metal 48%
20. Immunocompetent Cell 46%
21. Gallium 68 44%
22. Fat Content 43%
23. Adult 43%
24. Serum 41%
25. Obesity 40%
26. Physical Activity 39%
27. Cell Activation 38%
28. Serositis 38%
29. Myocarditis 37%
30. N Sec Butyl 1 (2 Chlorophenyl) N Methyl 3 Isoquinolinecarboxamide C 11 35%
31. Hip Arthroplasty 34%
32. Autoradiograph 34%
33. Metabolite 33%
34. Antagonist 32%
35. Aerobic Exercise 32%
36. Evaluation Study 31%
37. Skeletal Muscle 27%
38. Myocardium 26%
39. Muscle 26%
40. Fluorodeoxyglucose F 18 25%
41. Head and Neck Squamous Cell Carcinoma 24%
42. Head and Neck Cancer 24%
43. Neoplasm 24%
44. Malignant Neoplasm 24%
45. 3 Hydroxykynurenine 24%
46. Kynurenine 24%
47. Woman 24%
48. Ligand 21%
49. Follow up 20%
50. Combination Therapy 19%
51. Diagnosis 16%
52. High Intensity Interval Training 16%
53. Tryptophan 16%
54. Metabolic Syndrome 16%
55. Radioligand 16%
56. Cardiac Sarcoidosis 16%
57. Ventral Striatum 16%
58. Brain Disease 16%
59. Clinical Study 16%
60. Human 16%
61. Receptor Occupancy 16%
62. G Protein Coupled Receptor 16%
63. Receptor Subtype 16%
64. κ-Opioid Receptor 16%
65. Opiate 16%
66. Tissues 15%
67. Insulin Resistance 14%
68. Insulin 14%
69. Expanded Disability Status Scale 14%
70. Measurement 14%
71. Brain Ischemia 13%
72. Learning 13%
73. Accuracy 13%
74. Head 13%
75. Quantitative Insulin Sensitivity Check Index 13%
76. Glucose 12%
77. Body Mass Index 11%
78. Leptin 11%
79. Protein Intake 10%
80. Body Fat 10%
81. Nutrient Intake 10%
82. Freund Adjuvant 10%
83. Age 10%
84. Receptor Expression 10%
85. Nuclear Magnetic Resonance Spectroscopy 9%
86. Disability 9%
87. Enalapril Maleate 9%
88. B Cell 9%
89. Relapse 9%
90. Disease Exacerbation 9%
91. Brain Areas 9%
92. Maturity Onset Diabetes of the Young 9%
93. Magnetic Resonance Imaging 9%
94. PET-CT 9%
95. Glucosamine 9%
96. Marker 9%
97. Laboratory 8%
98. Metabolomics 8%
99. Blood 8%
100. White Matter Lesion 8%